Label Changes for:
Viracept (nelfinavir mesylate) Oral Powder, 50 mg/gViracept (nelfinavir mesylate) Tablets, 250 mgViracept (nelfinavir mesylate) Tablets, 625 mg
Changes have been made to the PRECAUTIONS sections of the safety label.
Detailed View: Safety Labeling Changes Approved By FDA Center for Drug Evaluation and Research (CDER)
7 DRUG INTERACTIONS
7.3 Established and Potentially Significant Drug Interactions
- added.........omeprazole: Omeprazole decreases the plasma concentrations of nelfinavir.Concomitant use of proton pump inhibitors and VIRACEPT may lead to a loss of virologic response and development of resistance